Related Experiment Video
Updated: Jul 14, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Carbohydrate counting implementation on pediatric type 1 diabetes mellitus: systematic review and meta-analysis
Lowilius Wiyono1, Nida Ghitha1, Dina Clarisa1
1Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Insights
Carbohydrate counting effectively reduces hemoglobin A1c (HbA1c) in children with type 1 diabetes mellitus. This management strategy improves glycemic control, offering a valuable approach for pediatric diabetes care.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Evidence-Based Medicine
Background:
- Type 1 diabetes mellitus (T1DM) is the most prevalent form of diabetes in children.
- Effective management of T1DM is crucial for preventing long-term complications and maintaining quality of life.
- Carbohydrate counting is a key dietary management strategy for T1DM.
Purpose of the Study:
- To systematically review and meta-analyze the efficacy of carbohydrate counting in reducing HbA1c levels in pediatric T1DM patients.
- To evaluate the impact of carbohydrate counting on glycemic control in children with T1DM.
Main Methods:
- A systematic review and meta-analysis of nine relevant studies.
- Searched electronic databases including ProQuest, PubMed, Scopus, and ScienceDirect.
- Assessed study quality using risk of bias and JBI Critical Appraisal tools.
- Performed quantitative analysis and forest plot extrapolation.
Main Results:
- Meta-analysis of nine studies involving pediatric T1DM patients demonstrated a significant reduction in HbA1c.
- Carbohydrate counting intervention resulted in a mean HbA1c difference of -0.55 (95% CI, -0.81 to -0.28; P<0.001) compared to control groups.
- High heterogeneity (I2=88%) was noted across the included studies, indicating variability in results.
Conclusions:
- The meta-analysis provides evidence supporting the use of carbohydrate counting in managing T1DM in children.
- Carbohydrate counting is an effective intervention for improving glycemic control in pediatric patients with type 1 diabetes mellitus.
Purpose:
Type 1 diabetes mellitus, which is the most common type of diabetes among children, is not curable but can be managed well without a negative effect on quality of life. One of the treatments of type 1 diabetes mellitus is carbohydrate counting. This systematic review and meta-analysis sought to evaluate the efficacy of carbohydrate counting with regard to hemoglobin A1c (HbA1c) reduction in children with type 1 diabetes mellitus.
Methods:
Nine studies were assessed, with the primary outcome being glycemic control (HbA1c changes). We searched the following electronic databases: ProQuest, PubMed, Scopus, and ScienceDirect. The quality of studies included was assessed using the risk of bias for randomized control trials and the JBI Critical Appraisal Checklist for observational and cross-sectional studies. Quantitative analyses were made and extrapolated into a forest plot.
Results:
A total of 1,693 articles were identified. Four reviewers independently screened titles and abstracts. Of the 36 articles screened, 34 articles were found to be eligible. Of these, 25 studies were excluded because of unsuitable outcomes and study designs. Nine articles were included in the final analysis. Meta-analysis showed that there was a reduction in HbA1c in the carbohydrate counting group as compared to the control group. The cumulative effect of carbohydrate counting on HbA1c was a mean difference of -0.55 (95% confidence interval, -0.81 to -0.28, P<0.001). All of the studies exhibited similar results with the mean difference reduction favoring the interventional group. However, the heterogeneity analysis revealed an I2 value of 88%, implying high heterogeneity in the meta-analysis.
Conclusion:
The meta-analysis showed evidence favoring the use of carbohydrate counting in the management of type 1 diabetes mellitus.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational

